澳华内镜: 持股5%以上股东减持股份计划公告

Group 1 - The core point of the announcement is that major shareholders of Shanghai Aohua Endoscopy Co., Ltd. plan to reduce their holdings by a total of up to 1,252,840 shares, which is approximately 0.93% of the company's total share capital [1][9] - The shareholders involved in the reduction are Gu Kang, Gu Xiaozhou, and their controlled entity, Shanghai Xiaozhou Optoelectronics Technology Co., Ltd., which collectively hold 41,822,800 shares, accounting for 31.06% of the company's total shares [2][9] - The reduction will be executed through centralized bidding and block trading methods, with the reduction period starting 15 trading days after the announcement and lasting for three months [1][4] Group 2 - The reason for the share reduction is attributed to the funding needs of Su Min Investment Junxin (Shanghai) Industrial Upgrade and Technological Innovation Equity Investment Partnership (Limited Partnership), a shareholder of Xiaozhou Optoelectronics [2][9] - The major shareholders have committed not to participate in this reduction, ensuring that their indirect holdings through Xiaozhou Optoelectronics will not be affected [2][9] - The announcement confirms that the reduction plan complies with relevant laws and regulations, and it will not impact the company's governance structure or ongoing operations [9]